Visual Assessment of Age-Related White Matter Hyperintensities Using FLAIR Images at 3 T: Inter- and Intra-Rater Agreement

2015 ◽  
Vol 16 (3-4) ◽  
pp. 279-283 ◽  
Author(s):  
Claire Boutet ◽  
Laure Rouffiange-Leclair ◽  
Fabien Schneider ◽  
Jean-Philippe Camdessanché ◽  
Jean-Christophe Antoine ◽  
...  
Keyword(s):  
White Matter ◽  
White Matter Hyperintensities ◽  
Visual Assessment ◽  
Rater Agreement ◽  
Age Related

scholarly journals Amyloid burden and white matter hyperintensities mediate age-related cognitive differences

2020 ◽  
Vol 86 ◽  
pp. 16-26 ◽  
Author(s):  
Pénélope Sévigny Dupont ◽  
Christian Bocti ◽  
Maude Joannette ◽  
Marie Maxime Lavallée ◽  
Jim Nikelski ◽  
...  
Keyword(s):  
White Matter ◽  
White Matter Hyperintensities ◽  
Amyloid Burden ◽  
Cognitive Differences ◽  
Age Related

Development and validation of morphological segmentation of age-related cerebral white matter hyperintensities

NeuroImage ◽  
2009 ◽  
Vol 47 (1) ◽  
pp. 199-203 ◽  
Author(s):  
Richard Beare ◽  
Velandai Srikanth ◽  
Jian Chen ◽  
Thanh G. Phan ◽  
Jennifer Stapleton ◽  
...  
Keyword(s):  
White Matter ◽  
White Matter Hyperintensities ◽  
Cerebral White Matter ◽  
Morphological Segmentation ◽  
Age Related ◽  
Development And Validation

Abstract MP057: Subclinical Cerebrovascular Disease is Associated with Worsening Gait and Balance in an Elderly Multi-Ethnic Population: The Northern Manhattan Study (NOMAS)

Circulation ◽  
2017 ◽  
Vol 135 (suppl_1) ◽  
Author(s):  
Joshua Z Willey ◽  
Yeseon Park Moon ◽  
Janet DeRosa ◽  
Erin Kulick ◽  
Sandino Cespedes ◽  
...  
Keyword(s):  
White Matter ◽  
Cerebrovascular Disease ◽  
White Matter Hyperintensities ◽  
Physical Aging ◽  
Disease Risk ◽  
Cardiovascular Disease Risk ◽  
The Elderly ◽  
Brain Regions ◽  
Periventricular White Matter ◽  
Age Related

Introduction: Age-related decline in gait and balance is a contributor to morbidity in the elderly. Subclinical cerebrovascular disease, seen on magnetic resonance imaging (MRI) as white matter hyperintensities (WMH) and silent brain infarcts (SBI), is associated with impaired mobility. Less is known about the association of WMH in specific brain regions and mobility impairment. We hypothesized that anterior WMH volume would be associated with lower scores on the Short Physical Performance Battery (SPPB), a well-validated mobility scale associated with falls and mortality in the elderly. Methods: Participants in the Northern Manhattan Study MRI cohort had the SPPB measured a median of 5 years after enrollment. The SPPB has three domains with a maximum total score of 12: gait speed, chair stands, standing balance. Volumetric distributions for WMH volume across 14 brain regions (brainstem, cerebellum, and bilateral frontal, occipital, temporal, and parietal lobes, and bilateral anterior and posterior periventricular white matter) were determined separately for each hemisphere by combining bimodal image intensity distribution and atlas based methods. Multi-variable linear regression was performed to examine the association between SBI and total and regional (frontal, parietal, occipital, temporal, anterior, posterior, and brainstem) head size-corrected WMH volumes, with the total SPPB score; models were adjusted for cardiovascular disease risk factors, osteo-arthritis, and grip strength. Results: Among 668 stroke-free participants with the SPPB available, mean age at the time of assessment was 74 ±9 years, 37% were male and 70% Hispanic; the mean SPPB score was 8.2 ± 2.9, interquartile range 7-10. Mean total WMHV was 0.55±0.75cc, mean anterior WMH volume 0.18±0.24cc, and 12% of participants had SBI. In multi-variable models, total WMHV was associated with a lower SPPB (beta = -0.3 per SD of logWMH, p=0.004), while SBI was not (beta= -0.12, p=0.7). For regional WMH volumes, only greater anterior periventricular WMHV was associated with SPPB (beta= -0.29 per SD, p=0.009). Conclusions: White matter hyperintensities, especially in the anterior cerebral regions, are associated with a lower SPPB. Prevention of subclinical cerebrovascular disease is a potential target to prevent physical aging in the elderly.

083 Response to immunosuppressive therapy in cerebral amyloid angiopathy-related inflammation

2018 ◽  
Vol 89 (6) ◽  
pp. A33.3-A34
Author(s):  
Jasmin Tilling ◽  
Benjamin Trewin ◽  
Stanley Levy
Keyword(s):  
White Matter ◽  
Cognitive Decline ◽  
Cerebral Amyloid Angiopathy ◽  
White Matter Hyperintensities ◽  
Neurological Deficits ◽  
Amyloid Angiopathy ◽  
Dramatic Improvement ◽  
Age Related ◽  
Cerebral Amyloid ◽  
The Brain

IntroductionCerebral amyloid angiopathy (CAA) is a common age-related condition characterised by amyloid beta-peptide deposition affecting the medium sized cortical and leptomeningeal arteries, arterioles and capillaries. CAA-related Inflammation (CAA-I) is an increasingly recognised variant of CAA, which is thought to be due to perivascular auto-inflammation in response to amyloid deposition. We describe the clinical course of two cases of probable CAA-I.CasesA 71 year old man presented with new-onset seizures, headaches and subacute cognitive decline. MRI of the brain demonstrated confluent subcortical T2 white matter hyperintensities and cerebral oedema, with predominantly superimposed widespread cortico-subcortical micro-haemorrhages, in keeping with the diagnosis of CAA-I. A course of immunosuppresive therapy was commenced with five days of intravenous methylprednisolone, resulting in marked radiological and clinical improvement within two weeks.A 76 year old female presented with subacute cognitive dysfunction and apraxia, and transient left-sided weakness. MRI scan of the brain initially demonstrated a right temporo-occipital infarct, leading to primary treatment for stroke, but subsequently evolved to reveal diffuse multi-lobar T2 white matter hyperintensities with leptomeningeal involvement. A provisional diagnosis of CAA-I was made and following a poor clinical response to a trial of corticosteroid therapy, treatment with intravenous cyclophosphamide was commenced.ConclusionThese cases emphasise the importance of CAA-I as part of the differential diagnosis in patients presenting with symptoms of subacute cognitive decline, seizures, headaches and focal neurological deficits, given the potential for dramatic improvement with readily accessible immunosuppressive therapies.

scholarly journals Longitudinal segmentation of age-related white matter hyperintensities

2017 ◽  
Vol 38 ◽  
pp. 50-64 ◽  
Author(s):  
Carole H. Sudre ◽  
M. Jorge Cardoso ◽  
Sebastien Ourselin
Keyword(s):  
White Matter ◽  
White Matter Hyperintensities ◽  
Age Related

scholarly journals White matter hyperintensities associated with small vessel disease impair social cognition beside attention and memory

2017 ◽  
Vol 38 (6) ◽  
pp. 996-1009 ◽  
Author(s):  
Jana Kynast ◽  
Leonie Lampe ◽  
Tobias Luck ◽  
Stefan Frisch ◽  
Katrin Arelin ◽  
...  
Keyword(s):  
Social Cognition ◽  
White Matter ◽  
Cognitive Decline ◽  
Cognitive Performance ◽  
White Matter Hyperintensities ◽  
Community Dwelling ◽  
Effect Sizes ◽  
Attention And Memory ◽  
Age Related ◽  
The Impact

Age-related white matter hyperintensities (WMH) are a manifestation of white matter damage seen on magnetic resonance imaging (MRI). They are related to vascular risk factors and cognitive impairment. This study investigated the cognitive profile at different stages of WMH in a large community-dwelling sample; 849 subjects aged 21 to 79 years were classified on the 4-stage Fazekas scale according to hyperintense lesions seen on individual T2-weighted fluid-attenuated inversion recovery MRI scans. The evaluation of cognitive functioning included seven domains of cognitive performance and five domains of subjective impairment, as proposed by the DSM-5. For the first time, the impact of age-related WMH on Theory of Mind was investigated. Differences between Fazekas groups were analyzed non-parametrically and effect sizes were computed. Effect sizes revealed a slight overall cognitive decline in Fazekas groups 1 and 2 relative to healthy subjects. Fazekas group 3 presented substantial decline in social cognition, attention and memory, although characterized by a high inter-individual variability. WMH groups reported subjective cognitive decline. We demonstrate that extensive WMH are associated with specific impairment in attention, memory, social cognition, and subjective cognitive performance. The detailed neuropsychological characterization of WMH offers new therapeutic possibilities for those affected by vascular cognitive decline.

scholarly journals White matter hyperintensities may be an early marker for age-related cognitive decline in the ADNI cohort

2021 ◽  
Author(s):  
Cassandra Morrison ◽  
Mahsa Dadar ◽  
Sylvia Villeneuve ◽  
D. Louis Collins
Keyword(s):  
White Matter ◽  
Cognitive Decline ◽  
White Matter Hyperintensities ◽  
White Matter Hyperintensity ◽  
Subjective Cognitive Decline ◽  
Age Related ◽  
Lower Baseline ◽  
Age Related Cognitive Decline ◽  
Linear Regressions

Background: Previous research suggests that white matter hyperintensities, amyloid, and tau contribute to age-related cognitive decline. It remains unknown as to how these factors relate to one another and how they jointly contribute to cognitive decline in normal aging. This project examines the association between these pathologies and their relationship to cognitive decline. Methods: Cognitively normal older adult data from the Alzheimers Disease Neuroimaging Initiative were examined. Participants were included if they had no subjective cognitive decline, had baseline white matter hyperintensity, CSF AB42/40, CSF pTau181, and cognitive scores. Of the 102 participants included, only 79 had follow-up cognitive scores. Linear regressions examined the influence of white matter hyperintensities, amyloid, and tau on baseline and follow-up cognitive scores. Linear regressions also examined the association of amyloid and tau on white matter hyperintensities and between tau and amyloid. Results: Increased white matter hyperintensity load was associated with lower baseline memory (B= -0.20, p =.046), follow-up executive functioning (B= -0.32, p<.001), and follow-up ADAS-13 (B=2.69, p<.001) scores. White matter hyperintensities were not related to pTau or AB42/40. Lower AB42/40 was associated with increased pTau (p=.025). pTau was not associated with decline in any cognitive score. Lower AB42/40 was associated with lower baseline (p=.015) but not follow-up executive function. Discussion: White matter hyperintensities may be one of the earliest pathologies observed in healthy older adults that contribute to cognitive decline. The inclusion of white matter hyperintensities as an additional marker for early cognitive decline may improve our current understanding of age-related changes.

Sign in / Sign up

Export Citation Format

Share Document